The intestinal microbiota and cellular therapy: implications for impact and mechanisms
Xie and Smith review the current understanding of the role of the microbiota and its diversity on responses to cellular therapies, including stem cell tran
Xie and Smith review the current understanding of the role of the microbiota and its diversity on responses to cellular therapies, including stem cell tran
Patients with relapsed ovarian cancer who had germline or somatic BRCA mutations saw greater OS with olaparib, according to data from the LIGHT trial.
Diagnosed with multiple myeloma in 2004, Vicki Jones has lived with her cancer for more than 20 years thanks to chemotherapy and immunotherapy.
Datopotamab deruxtecan approaches approval in Europe as an option for patients with previously treated hormone receptor–positive breast cancer.
Nature Reviews Cancer – Pet dogs with cancer facilitate comparative oncology, enhancing translational research. In this Comment, Lenz and Atherton highlight comparative oncology successes,…
Navtemadlin therapy demonstrated efficacy and safety for patients with JAK inhibitor relapsed/refractory myelofibrosis, as well as improved biomarkers of disease burden, according to data presented…
Key PointsBOVen was safe and effective for the frontline treatment of TP53-mutant MCL.The 2-year progression-free survival of 72% compares favorably with p
Join over 3,000 surgical oncologists worldwide. The Society of Surgical Oncology (SSO) is dedicated to improving multidisciplinary patient care by advancing the science, education, and…
Panelists discuss how myelofibrosis progresses from its molecular and genetic origins through various clinical manifestations, ultimately informing the development of targeted therapeutic approaches for this…
Panelists discuss Melinda’s experience with her lung cancer diagnosis, including her symptoms, diagnostic tests (such as imaging and blood work), and the progression of her…
Sintilimab with neoadjuvant chemoradiotherapy enhanced pCR rates in resectable, locally advanced esophageal squamous cell carcinoma.